Jane Street’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $68.1M | Buy |
152,500
+30,700
| +25% | +$14.3M | 0.01% | 861 |
|
|
2025
Q4 | $55.2M | Sell |
121,800
-23,200
| -16% | -$10M | 0.01% | 874 |
|
|
2025
Q3 | $56.8M | Buy |
145,000
+50,900
| +54% | +$21.3M | 0.01% | 888 |
|
|
2025
Q2 | $41.9M | Buy |
94,100
+7,000
| +8% | +$3.23M | 0.01% | 878 |
|
|
2025
Q1 | $42.2M | Sell |
87,100
-58,600
| -40% | -$27.3M | 0.01% | 757 |
|
|
2024
Q4 | $58.7M | Buy |
145,700
+38,300
| +36% | +$17.8M | 0.01% | 620 |
|
|
2024
Q3 | $49.9M | Buy |
107,400
+50,900
| +90% | +$24.5M | 0.01% | 692 |
|
|
2024
Q2 | $26.5M | Sell |
56,500
-33,300
| -37% | -$14.5M | 0.01% | 1080 |
|
|
2024
Q1 | $37.5M | Buy |
89,800
+7,700
| +9% | +$3.26M | 0.01% | 783 |
|
|
2023
Q4 | $33.4M | Sell |
82,100
-36,900
| -31% | -$13.6M | 0.01% | 902 |
|
|
2023
Q3 | $41.4M | Buy |
119,000
+49,800
| +72% | +$17.4M | 0.01% | 641 |
|
|
2023
Q2 | $24.4M | Sell |
69,200
-23,400
| -25% | -$7.88M | 0.01% | 1035 |
|
|
2023
Q1 | $29.2M | Buy |
92,600
+9,200
| +11% | +$2.76M | 0.01% | 773 |
|
|
2022
Q4 | $24.1M | Sell |
83,400
-6,400
| -7% | -$1.95M | 0.01% | 877 |
|
|
2022
Q3 | $26M | Sell |
89,800
-72,800
| -45% | -$20.9M | 0.01% | 876 |
|
|
2022
Q2 | $45.8M | Sell |
162,600
-41,400
| -20% | -$11.1M | 0.02% | 588 |
|
|
2022
Q1 | $53.2M | Sell |
204,000
-23,800
| -10% | -$5.65M | 0.02% | 659 |
|
|
2021
Q4 | $50M | Buy |
227,800
+53,200
| +30% | +$10.3M | 0.02% | 660 |
|
|
2021
Q3 | $31.7M | Sell |
174,600
-3,900
| -2% | -$761K | 0.01% | 818 |
|
|
2021
Q2 | $36M | Hold |
178,500
| – | – | 0.01% | 711 |
|
|
2021
Q1 | $38.4M | Buy |
178,500
+112,600
| +171% | +$24.7M | 0.02% | 585 |
|
|
2020
Q4 | $15.6M | Buy |
65,900
+15,300
| +30% | +$3.51M | 0.01% | 1055 |
|
|
2020
Q3 | $13.8M | Sell |
50,600
-144,700
| -74% | -$39.9M | 0.01% | 986 |
|
|
2020
Q2 | $56.7M | Buy |
195,300
+131,100
| +204% | +$35.5M | 0.04% | 318 |
|
|
2020
Q1 | $15.3M | Buy |
64,200
+35,100
| +121% | +$8.05M | 0.01% | 557 |
|
|
2019
Q4 | $6.37M | Sell |
29,100
-34,100
| -54% | -$6.9M | 0.01% | 901 |
|
|
2019
Q3 | $10.7M | Buy |
63,200
+42,300
| +202% | +$7.48M | 0.02% | 563 |
|
|
2019
Q2 | $3.83M | Sell |
20,900
-7,600
| -27% | -$1.33M | 0.01% | 1269 |
|
|
2019
Q1 | $5.24M | Buy |
28,500
+11,400
| +67% | +$2.11M | 0.01% | 1116 |
|
|
2018
Q4 | $2.83M | Sell |
17,100
-12,400
| -42% | -$2.15M | 0.01% | 1376 |
|
|
2018
Q3 | $5.69M | Sell |
29,500
-13,500
| -31% | -$2.4M | 0.01% | 948 |
|
|
2018
Q2 | $7.31M | Buy |
43,000
+21,700
| +102% | +$3.36M | 0.02% | 783 |
|
|
2018
Q1 | $3.47M | Buy |
21,300
+13,700
| +180% | +$2.24M | 0.01% | 1268 |
|
|
2017
Q4 | $1.14M | Sell |
7,600
-36,300
| -83% | -$5.37M | ﹤0.01% | 2195 |
|
|
2017
Q3 | $6.67M | Buy |
43,900
+14,900
| +51% | +$2.24M | 0.02% | 696 |
|
|
2017
Q2 | $3.74M | Sell |
29,000
-7,400
| -20% | -$891K | 0.01% | 965 |
|
|
2017
Q1 | $3.98M | Buy |
36,400
+27,300
| +300% | +$2.4M | 0.02% | 845 |
|
|
2016
Q4 | $670K | Sell |
9,100
-19,600
| -68% | -$1.59M | ﹤0.01% | 2525 |
|
|
2016
Q3 | $2.5M | Buy |
28,700
+23,600
| +463% | +$2.23M | 0.01% | 1019 |
|
|
2016
Q2 | $439K | Buy |
5,100
+1,100
| +28% | +$95K | ﹤0.01% | 2900 |
|
|
2016
Q1 | $318K | Buy |
4,000
+2,200
| +122% | +$199K | ﹤0.01% | 3134 |
|
|
2015
Q4 | $226K | Buy |
+1,800
| New | +$217K | ﹤0.01% | 3437 |
|
|
2015
Q3 | – | Sell |
-6,100
| Closed | -$753K | – | 4208 |
|
|
2015
Q2 | $753K | Buy |
+6,100
| New | +$769K | ﹤0.01% | 1857 |
|
Other funds holding VRTX
VCM
VPM
Jane Street's VRTX Position: Q1 2026 in Review
Jane Street increased its Vertex Pharmaceuticals (VRTX) stake by 993% in Q1 2026, buying an estimated $52.1M and bringing the position to 122,946 shares worth $54.9M. The position accounts for 0.01% of the portfolio, ranked #990.
Jane Street first reported a position in VRTX in Q2 2013 and has held it in 49 quarters since. The position peaked at $142M in Q2 2024. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Jane Street held 122,946 shares of Vertex Pharmaceuticals worth $54.9M as of Q1 2026.
- Jane Street bought 111,700 Vertex Pharmaceuticals shares in Q1 2026, an estimated $52.1M.
- Vertex Pharmaceuticals made up 0.01% of Jane Street's portfolio in Q1 2026, its #990 holding.
- Jane Street first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 49 quarters since.
- Jane Street's Vertex Pharmaceuticals position peaked at $142M in Q2 2024.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.